Medical Research Council (MRC) Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Flowers Building, Imperial College, London SW7 2AZ, UK.
Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada.
Nat Rev Microbiol. 2014 Sep;12(9):612-23. doi: 10.1038/nrmicro3315. Epub 2014 Aug 4.
Citrobacter rodentium is a mucosal pathogen of mice that shares several pathogenic mechanisms with enteropathogenic Escherichia coli (EPEC) and enterohaemorrhagic E. coli (EHEC), which are two clinically important human gastrointestinal pathogens. Thus, C. rodentium has long been used as a model to understand the molecular basis of EPEC and EHEC infection in vivo. In this Review, we discuss recent studies in which C. rodentium has been used to study mucosal immunology, including the deregulation of intestinal inflammatory responses during bacteria-induced colitis and the role of the intestinal microbiota in mediating resistance to colonization by enteric pathogens. These insights should help to elucidate the roles of mucosal inflammatory responses and the microbiota in the virulence of enteric pathogens.
柠檬酸杆菌是一种肠道病原体,与肠致病性大肠杆菌(EPEC)和肠出血性大肠杆菌(EHEC)有几个相似的致病机制,这两种细菌是两种具有临床重要意义的人类胃肠道病原体。因此,柠檬酸杆菌长期以来一直被用作研究 EPEC 和 EHEC 感染体内分子基础的模型。在这篇综述中,我们讨论了最近的研究,这些研究利用柠檬酸杆菌研究黏膜免疫学,包括细菌诱导结肠炎过程中肠道炎症反应的失调以及肠道微生物群在介导对肠道病原体定植的抵抗力中的作用。这些见解应该有助于阐明黏膜炎症反应和微生物群在肠道病原体毒力中的作用。